AUTL

Autolus Therapeutics

66 hedge funds and large institutions have $106M invested in Autolus Therapeutics in 2022 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 14 increasing their positions, 21 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding in top 10

Funds holding in top 10:

more first-time investments, than exits

New positions opened: | Existing positions closed:

less funds holding

Funds holding:

1.61% less ownership

Funds ownership: 55.92%54.3% (-1.6%)

27% less capital invested

Capital invested by funds: $144M → $106M (-$38.2M)

33% less repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 21

Holders
66
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$195K
Puts
$1K
Net Calls
Net Calls Change

Top Sellers

1 -$2.16M
2 -$637K
3 -$394K
4
Millennium Management
Millennium Management
New York
-$339K
5
IC
Ikarian Capital
Texas
-$133K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$38.5M
2
$15.7M
3
$11.2M
4
$8.02M
5
$6.5M
6
$3.58M
7
$2.93M
8
$2.44M
9
$1.49M
10
$1.34M
11
$1.25M
12
$1.18M
13
$1.06M
14
$956K
15
$947K
16
$916K
17
$839K
18
$834K
19
$816K
20
$768K
21
$556K
22
$437K
23
$318K
24
$290K
25
$285K